- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01671436
Meditation for Depression (CMIT)
Central Meditation and Imagery Therapy for Depression
Major Depressive Disorder (MDD) is a serious, costly and highly prevalent condition. However, currently available treatment options have limited efficacy. The aim of this pilot study is to determine whether patients suffering from MDD who have not responded to at least one antidepressant trial may actively engage in a novel group therapy, Central Meditation and Imagery Therapy (CMIT). Preliminary results with individual patients suggest that CMIT techniques may have benefit for major depression. The purpose of this trial is to assess the feasibility of a group form of CMIT for the treatment of major depression. The trial will also seek to identify neurophysiological and cardiovascular predictors of treatment response.
In this study, 10 subjects with major depressive disorder will receive antidepressant treatment augmentation with group meditation and mental imagery therapy for a total of 12 weeks, as well as daily meditation practice. Group sessions will also involve gentle yogic stretches. The subjects will be limited to those who remain depressed despite at least one trial of antidepressant medication. Changes in brain activity and heart rate variability will be measured at three time points utilizing electroencephalography (EEG) and pulse monitors. Depression symptoms will be measured at several time points using questionnaires and objective measures. Participation will require a total of 15 visits for weekly therapy and the measurements. Two-month follow-up questionnaires will be mailed to the subjects after study end to assess durability of any improvements in depressive symptoms.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
California
-
Los Angeles, California, Forenede Stater, 90024
- UCLA Semel Institute
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Meeting the DSM-IV criteria for unipolar major depressive disorder, as assessed by the Mini-Neuropsychiatric International Interview (MINI).
- HAM-D17 rating scale ≥ 14.
- Prior treatment with antidepressant medication during the present major depressive episode
- Adequate written and oral fluency in English to understand and complete study forms and converse with study personnel.
- Willingness on part of both subject and treating clinician to not change antidepressant treatment, including medications, psychotherapy or other treatments, over the course of the study, unless necessary to provide for well being of subject.
Exclusion Criteria:
- Current diagnosis of schizophrenia or any psychotic disorder including psychotic depression, dysthymia, mania or bipolar disorder, attention deficit or hyperactivity disorder, generalized anxiety disorder or panic disorder, obsessive compulsive disorder, alcohol or drug dependence, mental retardation, any pervasive developmental disorder or cognitive disorder (according to DSM-IV) criteria. Those with lifetime history of psychiatric conditions other than unipolar major depression will be also excluded.
- Medically unstable, delirious, or terminally ill (e.g. medical illness requiring hospitalization or intense outpatient management, such as heart disease; heart attack in the past 6 months; congestive heart failure; severe heart arrythmias; unstable hypertension; poorly controlled diabetes; or pending surgery).
- Past history of skull fracture; cranial surgery entering the calvarium; space occupying intracranial lesion; stroke/ aneurysm; Parkinson's or Huntington's disease; or Multiple Sclerosis.
- Participants regularly practicing (≥ 2 times per week) any of the techniques utilized in the study to reduce stress: meditation, guided imagery, yoga.
- Current treatment with behavior therapy or psychotherapy.
- Active suicidal plan as measured by HAM-D item 3 score of greater than or equal to 3, or history of suicide attempt during the current episode.
- Utilization of cannabis or other illicit drugs more than once a month.
- Excessive use of alcohol, i.e., men whose alcohol consumption exceeds 14 standard drinks per week or 4 drinks per day, and women whose alcohol consumption exceeds 7 standard drinks per week or 3 drinks per day.
- Needing to adjust or change anti-depressant treatment, including medications, psychotherapy, repetitive Transcranial Magnetic Stimulation (rTMS), Electroconvulsive Therapy (ECT), or Vagus Nerve Stimulation (VNS).
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Central Meditation and Imagery Therapy
Intervention involved Central Meditation, may be characterized by a voluntary, regulated attentional set towards a specific stimulus or set of stimuli and visualization exercises utilized within CMIT, which primarily involves two types of thought experiments: 1) creating mental models of how a person fits into the larger world and universe according to evolutionary biology and modern cosmology, in order to gain a larger perspective on emotions and thought patterns, and 2) backcasting, the generation of a desirable future coupled with mental time travel back to the present to determine how to create that future with present-day actions.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Hamilton Rating Scale for Depression (HAM-D)
Tidsramme: Measured 4 times over 12 weeks
|
Primary outcome is change in HAM-D from baseline to Week 12.
|
Measured 4 times over 12 weeks
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Quick Inventory of Depressive Symptoms- Self Report (QIDS- SR)
Tidsramme: Weekly assessments measured over 12 weeks, and 2 month follow-up
|
Weekly assessments measured over 12 weeks, and 2 month follow-up
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Felipe Jain, M.D., University of California, Los Angeles
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- CMIT-1042
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Depression
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RekrutteringAngst | Angst Depression | Depression Angstlidelse | Depression - svær depressiv lidelseNorge
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Aktiv, ikke rekrutterendeDepression Moderat | Depression Mild | Depression, teenagerForenede Stater
-
ProgenaBiomeTrukket tilbageDepression | Depression, postpartum | Depression, angst | Depression Moderat | Depression Alvorlig | Klinisk depression | Depression i remission | Depression, Endogen | Depression KroniskForenede Stater
-
Bekelu Teka WorkuJimma UniversityIkke rekrutterer endnuPrænatal depression | Mental sundhedsrelateret livskvalitet | Mødre postpartum depression | Faders postpartum depressionEtiopien
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryAktiv, ikke rekrutterendeDepression | Depression Moderat | Depression Alvorlig | Depression MildForenede Stater
-
Massachusetts General HospitalRekrutteringDepression | Depression - svær depressiv lidelse | Depression Kronisk | Depression hos voksne | Depressionslidelser | Depression lidelseForenede Stater
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRekrutteringDepression | Depression Moderat | Depression Alvorlig | Depression MildForenede Stater
-
Fondation FondaMentalGYNOVIkke rekrutterer endnuDepression | Depression hos voksne | Depression lidelseFrankrig
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RekrutteringMild depressionForenede Stater
-
University of MinnesotaAfsluttetDepression SymptomerForenede Stater
Kliniske forsøg med Central Meditation and Imagery Therapy
-
University of AmsterdamAfsluttetPosttraumatisk stresslidelse (PTSD)Holland
-
GGZ CentraalUtrecht UniversityAfsluttetPersonlighedsforstyrrelser | Stemningsforstyrrelser | Angstlidelser | MareridtHolland
-
Emory UniversityAfsluttet
-
University of California, San FranciscoAfsluttetBorderline personlighedsforstyrrelseForenede Stater
-
Ain Shams UniversityAfsluttetAutismespektrumforstyrrelseEgypten
-
University Hospital, GenevaAfsluttetPTSD | Mareridt, REM-søvntypeSchweiz
-
The Hong Kong Polytechnic UniversityIkke rekrutterer endnuDepression | Motoriske billeder | Rygmarvsskader (SCI) | Kognitive funktionerHong Kong
-
King's College Hospital NHS TrustKing's College London; Barts & The London NHS Trust; University Hospital... og andre samarbejdspartnereAfsluttet
-
Massachusetts General HospitalNational Institute on Aging (NIA)Afsluttet
-
University Hospital, GenevaAfsluttetMareridt, REM-søvntypeSchweiz